Companies similar to CUTANEOUS LYMPHOMA
Sign up to Download

91-120 of 52,190 results

  • www.biontech.com
  • 2
  • 3
  • 15
At BioNTech, we are humbled to contribute to the worldwide efforts to address the global COVID-19 pandemic. Within less than a year, we were able to develop our COVID-19 mRNA vaccine following highly scientific and ethical standards, which became the..
Relevance: 16.754814
  • www.kirschderm.com
  • 2
  • 5
Kirsch Dermatology offers surgical expertise for the excision of malignant and non-malignant growths of the skin, including basal cell carcinomas, squamous cell carcinomas, melanomas, skin tags, cysts and lipomas... Kirsch Dermatology offers new..
Relevance: 16.682423
  • www.kaedibio.com
  • 6
  • 1
  • 6
KAEDI is a new drug research and development company in the clinical stage that uses leading synthetic biology technologies to develop novel cell therapy drugs for the clinically unmet needs of patients with solid tumors. Relying on its advanced..
Relevance: 16.633247
  • www.genecellbt.com
  • 1
  • 5
  • 1
GeneCELL BT is dedicated to the cure of cancer and autoimmune diseases through the use of immune cell therapies, CAR-T, CAR-NK and CAR-Macrophage... We have focused initially on CAR-T treatment therapies because T cells are the most powerful cells..
Relevance: 16.610052
  • www.wooldridgetcell.org
  • 1
  • 1
  • 4
Our overall aim is to understand the mechanisms of CD8+ T-cell mediated disease and use this knowledge to develop novel therapeutic reagents...
Relevance: 16.561707
  • www.hershbhargava.com
  • 1
We built a synthetic circuit that wires tumor antigen detection to cytokine production in T cells. This circuit produces the inflammatory cytokine IL-2 at super-physiological levels, and enables engineered T cells to overcome imunosuppressive "cold"..
Relevance: 16.559448
  • www.jpt.com
  • 20
  • 26
  • 6
JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune..
Relevance: 16.556786
  • verikbio.com
  • 1
  • 1
  • 6
Verik Bio is making solid progress on solid tumor cancers, developing systems, technology and strategies to achieve High Curative Potential (HCP) with adoptive T-cell immunotherapy... Verik has called on seasoned veterans of biotech, pharma, and..
Relevance: 16.530071
  • cell-source.com
  • 1
  • 3
  • 7
Cell Source is a biotechnology company focused on developing cell therapy treatments based on the management of immune tolerance. Our patented Veto Cell technology is the centerpiece of treatment protocols that represent major breakthroughs in immune..
Relevance: 16.526604
  • www.connectamericatoday.com
AT&T is working to enhance our network through deploying new enhancements called small cells... Think of small cell as a mini-cell site - they support traditional macro cell towers by bolstering coverage and capacity in targeted areas where it's..
Relevance: 16.509247
  • celularity.com
  • 24
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent..
Relevance: 16.507004
  • www.neomicsbio.com
  • 1
Neomics is developing novel and more effective T cell-based therapy to treat broad types of cancers and immune diseases... Although evidence has long supported that the third-generation CARs, which integrate two co-stimulatory domains of CD28 and..
Relevance: 16.462282
  • www.t-fitness-horizon.eu
  • 1
The problem. Worldwide, an estimated 28.4 million new cancer cases are projected to occur in 2040, posing a considerable challenge to our society, science/technology and economy... The need. Immunotherapies, which target cancer cells by harnessing..
Relevance: 16.454556
  • minktherapeutics.com
  • 1
  • 1
  • 6
MiNK Therapeutics is a clinical-stage precision oncology company developing allogeneic, invariant natural killer T cell therapies for cancer and other immune-mediated diseases. The lead product is an off-the-shelf, cell therapy based on a targeted..
Relevance: 16.429058
  • www.tcell.com.tw
  • 1
Developed the "T-CELL", "C-PLUS" the series pellet lactobacillus products, the chitin and the lactobacillus were intergraded to promotes the efficiency of these products...
Relevance: 16.39226
  • miataproject.org
  • 4
  • 1
  • 1
Analysis of antigen-specific T cell responses has become a widely used tool in immune monitoring. Although an increasing number of promising data from correlative studies has been published and the variables of assay conduct which affect the quality..
Relevance: 16.35577
  • repeatertechnologies.com
  • 1
  • 1
  • 1
Telcosat has been here for the long haul and we have truly earned our stripes and battle scars. And now, with the imminent release of a new range of multi-band cell phone repeaters, we are once again ready to provide cell phone signal coverage to..
Relevance: 16.341427
  • ancorabiotech.com
Ancora Biotech LLC is a privately held company supporting the clinical development of three multi-specific antibodies. These three antibodies are held in separate spin-offs, namely: 1) TeneoTwo holds our clinical stage TNB-486 (anti-CD19xCD3) T cell..
Relevance: 16.333683
  • abatatx.com
  • 3
  • 18
Abata was launched in 2021 by Third Rock Ventures with a $95 million Series A financing and brings together industry experts and deeply engaged pioneers in regulatory T cell (Treg) biology, T cell receptor (TCR) and antigen discovery, disease..
Relevance: 16.321423
  • tcelljsc.com
  • 1
  • 2
T-Cell is the contributor of some of the best and most effective Dermatologist endorsed cosmeceuticals in the world- delighting consumers with transformative products and experiences. T-Cell is the contributor of some of the best and most effective..
Relevance: 16.310637
  • www.tt4cl-h2020.eu
  • 2
  • 1
TT4CL (Targeted treatment for cutaneous leishmaniasis) is a new Horizon 2020-funded project which aims to reduce the burden of a Neglected Tropical Diseases (NTD) and its social and economic impacts. Horizon 2020, the European Union's (EU) research..
Relevance: 16.30677
  • www.younevercall.com
  • 2
  • 1
Now we specialize in SmartPhones like the popular TMobile, Verizon and Sprint Android phones! We are here to help you choose the best cell phone deals from T-Mobile, Verizon Wireless, or Sprint. We can also help you compare cell phone plans to pick..
Relevance: 16.300028
  • www.mabtech.com
  • 25
  • 18
  • 21
ELISpot is commonly used to investigate antigen-specific immune responses and to discriminate between subsets of activated T cells. This is applied in studies of infectious diseases, cancer, allergies, and autoimmune diseases. In vaccine research,..
Relevance: 16.29928
  • bioriental.net
  • 1
Since the two cell lines are identical except for the presence of the transgene, and there is clear evidence in the literature that neither of these cell lines are very immunogenic when inoculated into normal WT mice [15], our results strongly..
Relevance: 16.295383
  • www.best-cellphone-plans.com
Cricket Wireless is one of the best prepaid cell phone plans in the market. Cricket started out with modest beginnings but is now a major player among low-cost, non-contract mobile providers. Cricket Mobile is owned by AT&T and offers cheaper plans..
Relevance: 16.289568
  • biovetica.com
  • 1
  • 1
We believe in the current biologic therapy and aim to develop immunotherapy treatments involving the upcoming technologies of cell therapy such as TIL and CAR-T...
Relevance: 16.266975
  • pancancer-t.com
  • 1
  • 13
Pan Cancer T is an immunotherapy company developing next-generation TCR-T cell therapies for solid cancer... TCR-T therapy is based on genetically modified T cells directed against specific targets on tumor cells. Pan Cancer T´s differentiated Next..
Relevance: 16.261139
  • roychoudhurilab.org
  • 8
  • 1
  • 10
Our laboratory, led by Dr Rahul Roychoudhuri, is located at the University of Cambridge Department of Pathology and works closely with collaborators within both the University and broader Cambridge immunology community. Our work benefits from access..
Relevance: 16.245516
  • www.tecartushcp.com
TECARTUS is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the YESCARTA and TECARTUS REMS Program... TECARTUS is a CD19-directed genetically modified autologous T cell immunotherapy..
Relevance: 16.225765
  • www.icellphonedeals.com
  • 1
Welcome to iCellPhoneDeals.com, your online guide to the best cell phone deals and reviews. We search the Internet daily for the latest promos from major wireless carriers. We are committed to become your ultimate online guide to cell phones and..
Relevance: 16.210194